Atossa Therapeutics, Inc. (ATOS)
5.33
-0.04
(-0.74%)
USD |
NASDAQ |
May 01, 16:00
5.365
+0.04
(+0.66%)
After-Hours: 20:00
Atossa Therapeutics EPS Diluted (Quarterly) : -1.270 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Cell Source, Inc. | -0.0153 |
| Kiora Pharmaceuticals, Inc. | -1.732 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.94M |
| Total Expenses (Quarterly) | 10.94M |
| Enterprise Value | 4.490M |
| Earnings Yield | -62.10% |
| Normalized Earnings Yield | -62.09 |